96 related articles for article (PubMed ID: 8454717)
1. Conformational changes of brain-derived neurotrophic factor during reversed-phase high-performance liquid chromatography.
Rosenfeld R; Benedek K
J Chromatogr; 1993 Feb; 632(1-2):29-36. PubMed ID: 8454717
[TBL] [Abstract][Full Text] [Related]
2. Refolding of brain-derived neurotrophic factor from guanidine hydrochloride: kinetic trapping in a collapsed form which is incompetent for dimerization.
Philo JS; Rosenfeld R; Arakawa T; Wen J; Narhi LO
Biochemistry; 1993 Oct; 32(40):10812-8. PubMed ID: 8399230
[TBL] [Abstract][Full Text] [Related]
3. Dimeric structure and conformational stability of brain-derived neurotrophic factor and neurotrophin-3.
Radziejewski C; Robinson RC; DiStefano PS; Taylor JW
Biochemistry; 1992 May; 31(18):4431-6. PubMed ID: 1581298
[TBL] [Abstract][Full Text] [Related]
4. Comparative equilibrium denaturation studies of the neurotrophins: nerve growth factor, brain-derived neurotrophic factor, neurotrophin 3, and neurotrophin 4/5.
Timm DE; de Haseth PL; Neet KE
Biochemistry; 1994 Apr; 33(15):4667-76. PubMed ID: 8161524
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human brain-derived neurotrophic factor (rHuBDNF). Disulfide structure and characterization of BDNF expressed in CHO cells.
Acklin C; Stoney K; Rosenfeld RA; Miller JA; Rohde MF; Haniu M
Int J Pept Protein Res; 1993 Jun; 41(6):548-52. PubMed ID: 8349412
[TBL] [Abstract][Full Text] [Related]
6. A common mechanism for recombinant human NGF, BDNF, NT-3, and murine NGF slow unfolding.
De Young LR; Schmelzer CH; Burton LE
Protein Sci; 1999 Nov; 8(11):2513-8. PubMed ID: 10595557
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of recombinant human brain-derived neurotropic factor unfolding under reversed-phase liquid chromatography conditions.
Benedek K
J Chromatogr; 1993 Aug; 646(1):91-8. PubMed ID: 8080476
[TBL] [Abstract][Full Text] [Related]
8. RhNGF slow unfolding is not due to proline isomerization: possibility of a cystine knot loop-threading mechanism.
De Young LR; Burton LE; Liu J; Powell MF; Schmelzer CH; Skelton NJ
Protein Sci; 1996 Aug; 5(8):1554-66. PubMed ID: 8844846
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of neurotrophin dimers and monomers.
Kolbeck R; Jungbluth S; Barde YA
Eur J Biochem; 1994 Nov; 225(3):995-1003. PubMed ID: 7957235
[TBL] [Abstract][Full Text] [Related]
10. Acid-induced unfolding of brain-derived neurotrophic factor results in the formation of a monomeric "a state".
Narhi LO; Rosenfeld R; Wen J; Arakawa T; Prestrelski SJ; Philo JS
Biochemistry; 1993 Oct; 32(40):10819-25. PubMed ID: 8399231
[TBL] [Abstract][Full Text] [Related]
11. Multiple peak formation from reversed-phase liquid chromatography of recombinant human platelet-derived growth factor.
Watson E; Kenney WC
J Chromatogr; 1992 Aug; 606(2):165-70. PubMed ID: 1430012
[TBL] [Abstract][Full Text] [Related]
12. Sites of iodination in recombinant human brain-derived neurotrophic factor and its effect on neurotrophic activity.
Rosenfeld R; Philo JS; Haniu M; Stoney K; Rohde MF; Wu GM; Narhi LO; Wong C; Boone T; Hawkins NN
Protein Sci; 1993 Oct; 2(10):1664-74. PubMed ID: 8251941
[TBL] [Abstract][Full Text] [Related]
13. Molecular weights of glycosylated and nonglycosylated forms of recombinant human stem cell factor determined by low-angle laser light scattering.
Arakawa T; Langley KE; Kameyama K; Takagi T
Anal Biochem; 1992 May; 203(1):53-7. PubMed ID: 1381876
[TBL] [Abstract][Full Text] [Related]
14. Expression and characterization of recombinant human ciliary neurotrophic factor from Escherichia coli.
McDonald JR; Ko C; Mismer D; Smith DJ; Collins F
Biochim Biophys Acta; 1991 Aug; 1090(1):70-80. PubMed ID: 1883844
[TBL] [Abstract][Full Text] [Related]
15. Biochemical characterization of recombinant human nerve growth factor.
Schmelzer CH; Burton LE; Chan WP; Martin E; Gorman C; Canova-Davis E; Ling VT; Sliwkowski MB; McCray G; Briggs JA
J Neurochem; 1992 Nov; 59(5):1675-83. PubMed ID: 1402913
[TBL] [Abstract][Full Text] [Related]
16. Heterodimers of the neurotrophic factors: formation, isolation, and differential stability.
Radziejewski C; Robinson RC
Biochemistry; 1993 Dec; 32(48):13350-6. PubMed ID: 8241191
[TBL] [Abstract][Full Text] [Related]
17. Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor.
Lin LF; Zhang TJ; Collins F; Armes LG
J Neurochem; 1994 Aug; 63(2):758-68. PubMed ID: 8035200
[TBL] [Abstract][Full Text] [Related]
18. Determination of pituitary and recombinant human growth hormone molecular weights by modern high-performance liquid chromatography with low angle laser light scattering detection.
Stuting HH; Krull IS
J Chromatogr; 1991 Feb; 539(1):91-109. PubMed ID: 2013614
[TBL] [Abstract][Full Text] [Related]
19. Conformational studies of bovine alkaline phosphatase in hydrophobic interaction and size-exclusion chromatography with linear diode array and low-angle laser light scattering detection.
Krull IS; Stuting HH; Krzysko SC
J Chromatogr; 1988 Jun; 442():29-52. PubMed ID: 3417821
[TBL] [Abstract][Full Text] [Related]
20. Conformational effects in the high-performance liquid chromatography of proteins. Further studies of the reversed-phase chromatographic behavior of ribonuclease A.
Lu XM; Benedek K; Karger BL
J Chromatogr; 1986 May; 359():19-29. PubMed ID: 3733925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
